$1.950
+0.441 (+22.64%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de NBY por análisis de gráficos similares
Alphio's NBY stock price prediction model matches the current NovaBay Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.95 (+0.12%). The 1-week path is $1.97 (+0.96%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de NovaBay Pharmaceuticals Inc?
NovaBay Pharmaceuticals Inc (NBY) is not a strong buy for a beginner investor seeking long-term growth. Despite the recent price surge, the lack of positive financial performance, absence of strong trading signals, and neutral sentiment from hedge funds and insiders suggest that this stock does not align with the user's investment goals.
NBY cerró en $1.95 el Thursday, tras subir +22.64%
NovaBay Pharmaceuticals Inc (NBY) last closed at $1.95, gaining +22.64%. These facts feed the 1-day and 1-week NBY price prediction above.
Consenso de analistas
NovaBay Pharmaceuticals Inc (NBY): 4 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de NovaBay Pharmaceuticals Inc (NBY) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bearish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de NBY, ordenadas por similitud.
Análisis de estacionalidad de NBY
Historically the probability of a positive September return for NBY is 51.22%. September offers the highest probability of a positive month at 51.22%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de NBY
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Sep 2026 | $0.22 | $0.36 | $0.50 | -81.66% |
| Oct 2026 | $0.49 | $0.51 | $0.61 | -73.93% |
| Nov 2026 | $0.45 | $0.46 | $0.57 | -76.66% |
| Dec 2026 | $0.30 | $0.41 | $0.46 | -78.89% |
En 2026, se proyecta que NovaBay Pharmaceuticals Inc (NBY) oscile entre $0.22 y $0.61.
Previsión mensual de NovaBay Pharmaceuticals Inc para 2026
En Sep de 2026, se proyecta que NovaBay Pharmaceuticals Inc promedie $0.36, con un mínimo de $0.22 y un máximo de $0.50.
En Oct de 2026, se proyecta que NovaBay Pharmaceuticals Inc promedie $0.51, con un mínimo de $0.49 y un máximo de $0.61.
En Nov de 2026, se proyecta que NovaBay Pharmaceuticals Inc promedie $0.46, con un mínimo de $0.45 y un máximo de $0.57.
En Dec de 2026, se proyecta que NovaBay Pharmaceuticals Inc promedie $0.41, con un mínimo de $0.30 y un máximo de $0.46.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.